Skip to content
10-K

Annual Report

EMERGENT BIOSOLUTIONS INC. EBS

0001367644-26-000015

← back to feed
Filed
Feb 27, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Feb 19, 2026 51.77M sh
Shares Diluted FY 2025 · Dec 31, 2025 56.7M sh
Shares Diluted FY 2025 · Dec 31, 2024 53M sh
Shares Diluted FY 2025 · Dec 31, 2023 51.2M sh
Stock Repurchased FY 2025 · Dec 31, 2025 $24.9M
Stock Repurchased FY 2025 · Dec 31, 2024 $0
Stock Repurchased FY 2025 · Dec 31, 2023 $0
Capex FY 2025 · Dec 31, 2025 $13.8M
Capex FY 2025 · Dec 31, 2024 $22.9M
Capex FY 2025 · Dec 31, 2023 $51.6M
Operating Cash Flow FY 2025 · Dec 31, 2025 $170.6M
Operating Cash Flow FY 2025 · Dec 31, 2024 $58.7M
Operating Cash Flow FY 2025 · Dec 31, 2023 −$206.3M
Long Term Debt FY 2025 · Dec 31, 2025 $572.1M
Long Term Debt FY 2025 · Dec 31, 2024 $663.7M
Cash And Equivalents FY 2025 · Dec 31, 2025 $205.4M
Cash And Equivalents FY 2025 · Dec 31, 2024 $99.5M
Cash And Equivalents FY 2025 · Dec 31, 2023 $111.7M
Stockholders Equity FY 2025 · Dec 31, 2025 $522.6M
Stockholders Equity FY 2025 · Dec 31, 2024 $482.8M
Stockholders Equity FY 2025 · Dec 31, 2023 $649.3M
Current Liabilities FY 2025 · Dec 31, 2025 $132.2M
Current Liabilities FY 2025 · Dec 31, 2024 $162.4M
Total Liabilities FY 2025 · Dec 31, 2025 $796M
Total Liabilities FY 2025 · Dec 31, 2024 $906.9M
Current Assets FY 2025 · Dec 31, 2025 $662.5M
Current Assets FY 2025 · Dec 31, 2024 $598.7M
Total Assets FY 2025 · Dec 31, 2025 $1.32B
Total Assets FY 2025 · Dec 31, 2024 $1.39B
Eps Diluted FY 2025 · Dec 31, 2025 $0.93
Eps Diluted FY 2025 · Dec 31, 2024 −$3.60
Eps Diluted FY 2025 · Dec 31, 2023 −$14.85
Eps Basic FY 2025 · Dec 31, 2025 $0.98
Eps Basic FY 2025 · Dec 31, 2024 −$3.60
Eps Basic FY 2025 · Dec 31, 2023 −$14.85
Sga Expense FY 2025 · Dec 31, 2025 $186.1M
Sga Expense FY 2025 · Dec 31, 2024 $308M
Sga Expense FY 2025 · Dec 31, 2023 $368.4M
Rd Expense FY 2025 · Dec 31, 2025 $53.2M
Rd Expense FY 2025 · Dec 31, 2024 $70.7M
Rd Expense FY 2025 · Dec 31, 2023 $111.4M
Net Income FY 2025 · Dec 31, 2025 $52.6M
Net Income FY 2025 · Dec 31, 2024 −$190.6M
Net Income FY 2025 · Dec 31, 2023 −$760.5M
Operating Income FY 2025 · Dec 31, 2025 $100.1M
Operating Income FY 2025 · Dec 31, 2024 −$108.7M
Operating Income FY 2025 · Dec 31, 2023 −$726.4M
Cost Of Revenue FY 2025 · Dec 31, 2025 $326.2M
Cost Of Revenue FY 2025 · Dec 31, 2024 $681.3M
Cost Of Revenue FY 2025 · Dec 31, 2023 $705.4M
Revenue FY 2025 · Dec 31, 2025 $742.9M
Revenue FY 2025 · Dec 31, 2024 $1.04B
Revenue FY 2025 · Dec 31, 2023 $1.05B